Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2009 2
2010 2
2017 1
2019 1
2023 1
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Retraction.
[No authors listed] [No authors listed] Int J Gynaecol Obstet. 2023 Sep;162(3):1130. doi: 10.1002/ijgo.14995. Epub 2023 Jul 8. Int J Gynaecol Obstet. 2023. PMID: 37422702
El Sharkwy, I.A. and Abd El Aziz, W.M. (2019), Randomized controlled trial of N-acetylcysteine versus l-carnitine among women with clomiphene-citrate-resistant polycystic ovary syndrome. ...REFERENCE El Sharkwy I, Sharaf El-Din M. L-carnitine plus metf …
El Sharkwy, I.A. and Abd El Aziz, W.M. (2019), Randomized controlled trial of N-acetylcysteine versus l-carnitine among women …
Randomized controlled trial of N-acetylcysteine versus l-carnitine among women with clomiphene-citrate-resistant polycystic ovary syndrome.
El Sharkwy IA, Abd El Aziz WM. El Sharkwy IA, et al. Int J Gynaecol Obstet. 2019 Oct;147(1):59-64. doi: 10.1002/ijgo.12902. Epub 2019 Jul 17. Int J Gynaecol Obstet. 2019. Retraction in: Int J Gynaecol Obstet. 2023 Sep;162(3):1130. doi: 10.1002/ijgo.14995. PMID: 31273783 Retracted. Clinical Trial.
OBJECTIVE: To compare clinical and metabolic profiles between N-acetylcysteine and l-carnitine among women with clomiphene citrate (CC)-resistant polycystic ovary syndrome (PCOS). ...CONCLUSIONS: Both N-acetylcysteine and l-carniti …
OBJECTIVE: To compare clinical and metabolic profiles between N-acetylcysteine and l-carnitine among women with clomiphene …
Effect of N-acetyl-cysteine after ovarian drilling in clomiphene citrate-resistant PCOS women: a pilot study.
Nasr A. Nasr A. Reprod Biomed Online. 2010 Mar;20(3):403-9. doi: 10.1016/j.rbmo.2009.12.012. Epub 2009 Dec 14. Reprod Biomed Online. 2010. Retraction in: Reprod Biomed Online. 2025 Nov;51(5):105286. doi: 10.1016/j.rbmo.2025.105286. PMID: 20089454 Retracted. Clinical Trial.
The aim of this randomized double-blind placebo-controlled pilot study was to evaluate N-acetyl-cysteine (NAC) as an adjunctive therapy following unilateral laparoscopic ovarian drilling (LOD) for clomiphene citrate-resistant women with polycystic ovary syndrome ( …
The aim of this randomized double-blind placebo-controlled pilot study was to evaluate N-acetyl-cysteine (NAC) as an adjunctive therapy foll …
N-acetyl-cysteine is a novel adjuvant to clomiphene citrate in clomiphene citrate-resistant patients with polycystic ovary syndrome.
Rizk AY, Bedaiwy MA, Al-Inany HG. Rizk AY, et al. Fertil Steril. 2005 Feb;83(2):367-70. doi: 10.1016/j.fertnstert.2004.07.960. Fertil Steril. 2005. PMID: 15705376 Free article. Clinical Trial.
OBJECTIVE: To evaluate the effect of N-acetyl-cysteine (NAC), a mucolytic drug with insulin sensitizing properties, as an adjuvant therapy in subjects with polycystic ovary syndrome (PCOS) resistant to clomiphene citrate (CC). DESIGN: Placebo-controlled, doub …
OBJECTIVE: To evaluate the effect of N-acetyl-cysteine (NAC), a mucolytic drug with insulin sensitizing properties, as an adjuvant therapy i …
Comparison of metformin and N-acetyl cysteine, as an adjuvant to clomiphene citrate, in clomiphene-resistant women with polycystic ovary syndrome.
Nemati M, Nemati S, Taheri AM, Heidari B. Nemati M, et al. J Gynecol Obstet Hum Reprod. 2017 Sep;46(7):579-585. doi: 10.1016/j.jogoh.2017.07.004. Epub 2017 Jul 8. J Gynecol Obstet Hum Reprod. 2017. PMID: 28698075 Clinical Trial.
OBJECTIVE: To evaluate the effects of short- and long-term treatment with metformin and NAC, in an adjuvant to clomiphene citrate (CC), on the improvement of hormonal profile (SHBG, total testosterone, FBS, and fasting insulin) and fertility status in CC-resistant w …
OBJECTIVE: To evaluate the effects of short- and long-term treatment with metformin and NAC, in an adjuvant to clomiphene citrate (CC …
Management strategies for ovulation induction in women with polycystic ovary syndrome and known clomifene citrate resistance.
Palomba S, Falbo A, Zullo F. Palomba S, et al. Curr Opin Obstet Gynecol. 2009 Dec;21(6):465-73. doi: 10.1097/GCO.0b013e328332d188. Curr Opin Obstet Gynecol. 2009. PMID: 19809318 Review.
About 60-85% of PCOS women ovulated under clomifene citrate, whereas the others were defined clomifene citrate-resistant. The purpose of the current review will be to describe treatment strategies to induce ovulation in infertile PCOS patients w …
About 60-85% of PCOS women ovulated under clomifene citrate, whereas the others were defined clomifene citrate-resis …
Letrozole for Ovulation Induction in Women With Polycystic Ovary Syndrome.
Li XL. Li XL. Obstet Gynecol Surv. 2026 Apr 1;81(4):186-191. doi: 10.1097/OGX.0000000000001494. Epub 2026 Apr 10. Obstet Gynecol Surv. 2026. PMID: 41950500 Free article. Review.
RESULTS: Letrozole, one of the third-generation of aromatase inhibitors, is increasingly recommended as a first-line agent for ovulation induction in anovulatory PCOS women due to better pregnancy and live birth rates, especially in those with clomiphene citrate (CC …
RESULTS: Letrozole, one of the third-generation of aromatase inhibitors, is increasingly recommended as a first-line agent for ovulation ind …
N-acetyl cysteine plus clomiphene citrate versus metformin and clomiphene citrate in treatment of clomiphene-resistant polycystic ovary syndrome: a randomized controlled trial.
Abu Hashim H, Anwar K, El-Fatah RA. Abu Hashim H, et al. J Womens Health (Larchmt). 2010 Nov;19(11):2043-8. doi: 10.1089/jwh.2009.1920. Epub 2010 Oct 12. J Womens Health (Larchmt). 2010. PMID: 20939675 Clinical Trial.
OBJECTIVE: To compare the effects of combined N-acetyl cysteine (NAC) and clomiphene citrate (CC) and of combined metformin and CC on ovulation induction in anovulatory CC-resistant women with polycystic ovary syndrome (PCOS). ...CONCLUSIONS: The efficacy of …
OBJECTIVE: To compare the effects of combined N-acetyl cysteine (NAC) and clomiphene citrate (CC) and of combined metformin and CC on …